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C

lostridium difficile, an anaerobic, Gram-positive, spore-forming bacterium, is an emerging nosocomial pathogen and the
etiological agent of antibiotic-associated diarrhea and pseudomembranous colitis (1–3). In recent years, the severity and incidence of C. difficile infection have increased due to the emergence in North America and Europe of highly virulent NAP1/027
C. difficile strains (4, 5). Most pathogenic C. difficile strains produce two large cytotoxins (TcdA and TcdB) that are the primary
virulence factors (6, 7).
Toxin production in C. difficile responds to environmental
conditions, including the availability of specific nutrients, temperature changes, and alteration of the redox potential (8–10). In
addition, the presence of a rapidly metabolizable carbon source
(11, 12) or certain amino acids (13, 14) inhibits toxin gene expression. For instance, addition to the growth medium of a mixture of
nine amino acids (cysteine, isoleucine, leucine, valine, methionine, threonine, tryptophan, glycine, and proline) strongly reduces toxin yield (12, 14). When cells are grown in rich medium,
the toxin genes are transcribed only when the cells reach stationary
phase (11, 15).
Some of the molecular mechanisms regulating C. difficile toxin
gene expression have been elucidated (8, 11, 16–19). Transcription of the tcdA and tcdB genes depends on TcdR, an alternative
sigma factor that directs RNA polymerase to the toxin gene promoters (20). Transcription of the tcdR gene is repressed during the
rapid exponential growth phase by CodY, a global regulator of
metabolism and of genes that allow adaptation to nutrient limitation (19, 21). CodY is active in cells with an excess of branchedchain amino acids (isoleucine, leucine, and valine) and GTP (22–
24). When the cells reach stationary phase, the intracellular
concentrations of these ligands decrease and CodY is less able to
bind as a repressor, leading to derepression of tcdR transcription.
How C. difficile responds to the levels of other amino acids to
modulate toxin expression remains unclear.
The activity of TcdR is modulated by TcdC, an anti-sigma factor that destabilizes the TcdR– core RNA polymerase complex
(25). TcdC seems to be most active in rapidly growing cells. Other
sigma factors, such as SigD and SigH, are involved in toxin gene
transcription by unknown mechanisms (8, 18).
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Regulation of toxin production by the carbon source is mediated by CcpA, a global regulator of carbon metabolism in Grampositive bacteria (16). CcpA is a direct repressor of the tcdA and
tcdB genes. The roles of CodY and CcpA reflect a tight coupling
between metabolism and virulence in Clostridium spp. and other
pathogenic bacteria (26, 27).
In several nonpathogenic Clostridium species (e.g., C. sporogenes and C. sticklandii), amino acid metabolism by the Stickland
reactions is a primary source of energy when bacteria are grown
with amino acids as sole sources of carbon and nitrogen (28–31).
Stickland reactions couple metabolism of pairs of amino acids in
which one amino acid, acting as an electron donor, is oxidatively
deaminated or decarboxylated and a second amino acid, acting as
an electron acceptor, is reduced or reductively deaminated (Fig. 1).
The most efficient electron donors are leucine, isoleucine, and
alanine, and the most efficient acceptors are glycine, proline, and
hydroxyproline (30, 32, 33). In C. sticklandii, the reduction of the
Stickland acceptors glycine and proline is performed by two selenium-dependent reductases, glycine reductase (GR) and D-proline reductase (PR), respectively. GR catalyzes the reductive
deamination of glycine to acetyl phosphate and ammonium, and
PR reductively cleaves D-proline to 5-aminovalerate (34–37).
Jackson et al. (38) showed that C. difficile growth requires selenium in a limiting basal medium with torula yeast extract, suggesting a key role of the Stickland reactions in C. difficile physiology (39). Based on sequence homology to C. sticklandii, genes
encoding the C. difficile GR and PR subunits are clustered in two
distinct genetic loci (grd and prd, respectively) on the chromosome of C. difficile strain 630 (38). The grd locus contains eight
genes (Fig. 2). Two of the genes, grdA and grdB, likely encode the
selenocysteine-containing subunits of GR (38). The seven genes of
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Clostridium difficile, a proteolytic Gram-positive anaerobe, has emerged as a significant nosocomial pathogen. Stickland fermentation reactions are thought to be important for growth of C. difficile and appear to influence toxin production. In Stickland
reactions, pairs of amino acids donate and accept electrons, generating ATP and reducing power in the process. Reduction of the
electron acceptors proline and glycine requires the D-proline reductase (PR) and the glycine reductase (GR) enzyme complexes,
respectively. Addition of proline in the medium increases the level of PR protein but decreases the level of GR. We report the
identification of PrdR, a protein that activates transcription of the PR-encoding genes in the presence of proline and negatively
regulates the GR-encoding genes. The results suggest that PrdR is a central metabolism regulator that controls preferential utilization of proline and glycine to produce energy via the Stickland reactions.

Regulation of C. difﬁcile Stickland Reactions

MATERIALS AND METHODS

FIG 1 Overview of Stickland metabolism. Stickland reactions couple oxidation
and reduction of amino acid pairs. D-Proline reductase catalyzes the reductive
cleavage of the D-proline ring to yield ␦-aminovaleric acid. Glycine reductase catalyzes the reductive deamination of glycine to acetyl phosphate to generate ATP via
substrate-level phosphorylation through acetate kinase.

the putative prd operon (Fig. 2) include prdF, predicted to encode
a D-proline racemase, and prdB, predicted to encode the seleniumcontaining subunit of PR. It is interesting to note that proP, downstream of the grd operon, is predicted to encode a proline amino-

Strains and growth conditions. The bacterial strains and plasmids used
in this study are listed in Table 1. C. difficile strains were grown routinely
in TY medium (11), supplemented with 250 g/ml D-cycloserine, 40
g/ml kanamycin, 20 g/ml thiamphenicol, or 5 g/ml erythromycin as
needed. C. difficile strains were maintained at 37°C in an anaerobic chamber (Coy Laboratory Products) with an atmosphere of 10% H2, 5% CO2,
and 85% N2. Escherichia coli strains were grown at 37°C in L medium
supplemented with 20 g/ml chloramphenicol or 100 g/ml ampicillin,
as needed.
Growth behavior analyses of C. difficile strains were performed in TY
medium, with or without supplementation as indicated below, in a microtiter plate format. Briefly, mid-exponential-phase cultures adjusted to
an optical density at 600 nm (OD600) of 0.1 were diluted (1:10) in 200 l
TY medium supplemented with proline (30 mM) or glycine (30 mM) in
wells of a 96-well microtiter plate (Costar). Cultures were grown anaerobically at 37°C. At 10-min intervals over a 12-h period, the plates were
agitated for 2 min before the OD600 was recorded using a plate reader
(Bio-Tek). Data from two biological replicates, each with six technical
replicates, were used to construct the growth curve for each strain.
Strain and plasmid construction. Oligonucleotides used in this study
are listed in Table 2. C. difficile strain 630 DNA, GenBank accession number AM180355 (41), was used as a template for PCR amplification. Sequencing of cloned DNA fragments was performed by the Tufts University Core Facility using an ABI 3130XL DNA sequencer.
Null mutations in prdB and prdR were created in several steps. First,
plasmids pBL33 and pBL67 were constructed by retargeting of the erm

FIG 2 Organization of the D-proline reductase and glycine reductase gene clusters. Arrows indicate the locations of group II intron insertions in various mutant
strains. The coordinates refer to the positions of the gene clusters in the genome of C. difficile strain 630.
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peptidase, suggesting a link between metabolism of glycine and
that of proline (38). Moreover, Jackson et al. (38) found that proline and glycine specifically stimulate production of the selenoenzymes PR and GR, respectively. Interestingly, addition to the medium of glycine and proline in combination with other amino
acids has been shown to decrease toxin yield (14). Therefore, a
detailed understanding of the amino acid metabolism pathways
and their regulation may give important insights into C. difficile
pathogenesis.
In this study, we investigated the transcriptional regulation of
the C. difficile grd and prd gene clusters. We found that addition of
proline to the growth medium increases the expression of the prd
operon and decreases the expression of the grd operon. By constructing prd and grd null mutant strains, we were able to demonstrate the interdependent regulation of the two operons. That is,
expression of a functional PR decreased transcription of the grd
operon. Furthermore, we identified PrdR, the product of a gene
located upstream of the prd operon, as the mediator of prolinedependent activation of the prd operon and proline-dependent
repression of the grd operon.

Bouillaut et al.

TABLE 1 Bacterial strains and plasmids used in this study
Strain or plasmid
Strains
E. coli
HB101
DH5␣
C. difficile
JIR8094
LB-CD4
LB-CD12
LB-CD8
LB-CD13
LB-CD14

Reference or source

F⫺ supE44 hsdS20(rB⫺ mB⫺) recA13 ara-14 proA2 lacY1 galK2 rpsL20 xyl-5 mtl-1
fhuA2 ⌬(argF-lacZ)U169 phoA glnV44 ⌽80 ⌬(lacZ)M15 gyrA96 recA1 relA1 endA1 thi-1 hsdR17

B. Dupuy
New England Biolabs, USA

Ems derivative of strain 630
JIR8094 prdB::ermB
JIR8094 grdA::ermB
JIR8094 prdR::ermB
JIR8094 pBL58
LB-CD8 pBL93

19
This study
This study
This study
This study
This study

pCE240 targeted to prdB
pCR2.1-intron template part A
pCR2.1-intron template part B
pCE240 targeted to prdR
pMC123 without HindIII and BsrGI sites
pMC123 containing groupII intron targeted to prdR from pBL67
pBL100 targeted to grdA
pBL68 containing prdR
pBL68 containing un-targeted groupII intron–TargeTron vector
Derivative of pJIR750ai (Sigma-Aldrich), Tmr

This study
This study
This study
This study
This study

Ampr Tcr
Tra⫹ Mob⫹ Ampr Tcr

gene-containing group II intron from pCE240 (42), using for prdB the
primers oLB64, oLB65, oLB66, and the EBS Universal primer and for prdR
the primers oLB102, oLB103, oLB104, and the EBS Universal primer as
outlined in the TargeTron user manual (Sigma-Aldrich), followed by initial cloning of the retargeted fragment in pCE240 digested with BsrGI/
HindIII. Plasmid pCE240 is a derivative of pJIR750ai (Sigma-Aldrich)
and is similar to pMTL007 (43). The retargeted group II intron from
pBL67 was then extracted by digestion with SfoI and SphI and cloned
between the SphI and SnaBI sites of pMC123 (44), resulting in pBL71.
pBL33 (targeted for prdB) and pBL71 (targeted for prdR) were then introduced by transformation into E. coli strain HB101(pRK24). pRK24 is a
derivative of the broad-host-range plasmid RP4, which mobilizes IncP
oriT plasmids. The resulting strains were then mated with C. difficile strain
JIR8094, resulting in transfer of pBL33 and pBL71 by conjugation, as
previously described (45), except that transconjugants were selected on
BHIS plates (45) supplemented with D-cycloserine, kanamycin, and thiamphenicol. Inactivation of prdB and prdR was selected for by screening
transconjugants for erythromycin resistance, resulting in strains LB-CD4
and LB-CD8, respectively. These strains were also thiamphenicol sensitive, indicating that they no longer carried the replicating plasmid. Insertional disruption of prdB or prdR was confirmed using primer pairs
oLB78/oLB79 and oLB120/oLB121, which anneal outside the region of
insertion in the prdB and prdR genes, respectively.
To interrupt grdA and to make future mutant construction in C.
difficile easier, we created a new set of plasmids for retargeting of the
group II intron. We amplified two portions of the intron by PCR using
pBL71 as the template and primers oLB102/EBS Universal and
oLB103/oLB104. Amplicons were TA cloned in the pCR2.1 vector (Invitrogen), resulting in pBL64 and pBL65. A mixture (1:1) of pBL64 and
pBL65 was used as the template to generate the retargeted intron fragment by mutagenic PCR.
We generated a grdA targeted intron fragment using primers oLB99,
oLB100, oLB101, and EBS Universal and a pBL64-pBL65 mixed template.
Following HindIII/BsrGI digestion, the PCR fragment was cloned in HindIII/BsrGI-digested pBL100 (see below). The resulting plasmid, pBL91,
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This study
This study
42
Invitrogen
44
45

was introduced into E. coli strain HB101(pRK24), and the obtained strain
was subsequently mated with C. difficile JIR8094 as described above. Insertional disruption was verified by PCR using primers oLB118 and
oLB119.
To construct pBL100, the BsrGI and HindIII sites of pMC123 (44)
were first removed in multiple steps by PCR-directed mutagenesis and
blunting of digested DNA, creating pBL68. Then, pBL68 was digested by
EcoRI and blunted using Klenow fragment (New England BioLabs, USA)
and subsequently digested by SphI. The intron portion of pCE240 was
extracted by SphI/SfoI digestion and cloned in digested pBL68, yielding
pBL100.
To complement the prdR disruption, a 2,119-bp fragment containing
the prdR gene and its upstream region was amplified using primers
oLB187 and oLB188 and cloned between the EcoRI and HindIII sites of
pBL58, generating pBL93. This plasmid was introduced into LB-CD8 as
previously described (45), resulting in LB-CD14.
Southern hybridization. C. difficile genomic DNA was digested
with HindIII and subjected to agarose gel electrophoresis (0.8%). Digested DNA was then transferred to a nylon membrane (pore size ⫽
0.45 m) in 20⫻ saline-sodium citrate (SSC; 1⫻ SSC is 0.15 M NaCl
plus 0.015 M sodium citrate) according to the method of Southern
(46). The membrane was prehybridized for 3 h at 42°C in 50% formamide, 5⫻ SSC, 2⫻ Denhardt’s solution, and 100 mg denatured
salmon sperm DNA per ml. Overnight hybridization was carried out in
the same solution at 42°C with an intron-specific, 32P-labeled PCR
fragment generated using oLB277 and oLB278 as primers. The membrane was washed for 30 min in 1⫻ SSC– 0.1% SDS and for 30 min in
0.1⫻ SSC– 0.1% SDS at room temperature. Radioactive bands were
visualized by PhosphorImager analysis (Molecular Dynamics).
qPCR analysis. Cultures of C. difficile grown in TY medium were
harvested at OD600s of 0.4 to 0.7 (mid-exponential phase) or 1.2 to 1.4
(stationary phase), and DNA-free RNA was prepared as previously
described (19, 44). RNA was quantitated by absorbance (A260 and
A260/A280 ratio) using a NanoDrop ND-1000 spectrophotometer
(Thermo Scientific). Primers for quantitative reverse transcription-
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Plasmids
pBL33
pBL64
pBL65
pBL67
pBL68
pBL71
pBL91
pBL93
pBL100
pCE240
pCR2.1
pMC123
pRK24

Characteristics

Regulation of C. difﬁcile Stickland Reactions

TABLE 2 Primers used in this study
Sequence

EBS Universal
oLB64
oLB65
oLB66
oLB67
oLB78
oLB79
oLB99
oLB100
oLB101
oLB102
oLB103
oLB104
oLB118
oLB119
oLB120
oLB121
oLB122
oLB123
oLB131
oLB132
oLB261
oLB262
oLB265
oLB266
oLB170
oLB171
oLB176
oLB177
oLB187
oLB188
oLB221
oLB222
oLB277
oLB278

CGAAATTAGAAACTTGCGTTCAGTAAAC
AAAAGCTTTTGCAACCCACGTCGATCGTGAATTCTGCAGCTAAGTGCGCCCAGATAGGGTG
CAGATTGTACAAATGTGGTGATAACAGATAAGTCAGCTAATTTAACTTACCTTTCTTTGT
CGCAAGTTTCTAATTTCGGTTCAGAATCGATAGAGGAAAGTGTCT
AAAAGCTTTTGCAACCCACGTCGATCGTGAAGACCCAAGTAAAGTGCGCCCAGATAGGGTG
TCCTCCAGTTTGGACTCCTGTAAC
ATTGGAACTAATGGAGCAACTG
AAAAGCTTTTGCAACCCACGTCGATCGTGAACAGTTACTGTTTGTGCGCCCAGATAGGGTG
CAGATTGTACAAATGTGGTGATAACAGATAAGTCCTGTTTCGTAACTTACCTTTCTTTGT
CGCAAGTTTCTAATTTCGGTTAACTGTCGATAGAGGAAAGTGTCT
AAAAGCTTTTGCAACCCACGTCGATCGTGAAATGTATCATTTAGTGCGCCCAGATAGGGTG
CAGATTGTACAAATGTGGTGATAACAGATAAGTCCATTTACTTAACTTACCTTTCTTTGT
CGCAAGTTTCTAATTTCGGTTTACATTCGATAGAGGAAAGTGTCT
ATAATAGGTGACCGTGATGG
TTCTTCTCTTATACCAGACATTTC
ATAGGGATTCTTCCTGTTCTTAG
TCCTATGTCTTCTTTTCTCTCTCT
CTAGCTGCTCCTATGTCTCACATC
CCAGTCTCTCCTGGATCAACTA
GTATGGATAGGTGGAGAAGTCA
CTCTTCCTCTAGTAGCTGTAATGC
CTATAGACTCTCATACAGCAGGTG
CATTATGTCCTCTTGGCTCTAAC
GGGAGAGGGTATTACACATACT
GGAGTTCCATATCTCCCAAATACC
GGTCAAGTACTAGGAGCTAAGT
CTACTTCTTCTTTAGCCTCTCCTG
CCCTGGTATCATGTCTAAAGTTG
GAGTATACTTAGCTCCTTCTCCAG
CCCGAATTCTGGATACAGGCATTCATTAATTGT
CCCAAGCTTAACACATCTATATACACAACAC
GAACTCTAATCGCAGAACCAAC
CATTCCTACTACTCCAGCTTCT
GTAGGAGAACCTATGGGAAC
TCCTTACCATTTAAGCACAC

PCR (qPCR) were designed using the online PrimerQuest tool from
Integrated DNA Technologies (http://www.idtdna.com/Scitools
/Applications/Primerquest), and amplification efficiencies for each
primer set were determined prior to use. To control for chromosomal
DNA contamination, mock cDNA synthesis reaction mixtures containing no reverse transcriptase were used as negative controls in subsequent amplifications. cDNA samples were diluted 4-fold and used
as the templates for qPCR of rpoC (primers oLB122/oLB123),
prdA (primers oLB170/oLB171), prdC (primers oLB221/oLB222),
prdD (primers oLB265/oLB266), prdF (primers oLB261/oLB262),
grdE (primers oLB176/oLB177), and tcdA (primers oLB131/oLB132)
using Roche SYBR green I PCR mix and a Roche LightCycler 480 II
thermocycler. Reactions were performed in a final volume of 20 l
using 4 l diluted cDNA and 1 M each primer. Reactions were performed in triplicate using cDNA extracted from each of a minimum of
three biological replicates, and results are presented as the means and
standard deviations of the data obtained. Amplification included 45
cycles of the following steps: 10 s at 95°C, 10 s at 53°C, and 15 s at 72°C.
Results were calculated using the comparative cycle threshold method
(47), in which the amount of target mRNA is normalized to that of an
internal control transcript (rpoC).
Proline assay. Overnight cultures in TY medium were diluted in TY
medium to an OD600 of 0.05 and incubated anaerobically at 37°C. Cells
were harvested at mid-exponential growth phase (OD600 of 0.4 to 0.7) by
centrifugation (10 min at 4,000 rpm) and resuspended in 3% (wt/vol)
5-sulfosalicylic acid. Silica-glass beads (0.1 mm) were added, and cells
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were disrupted using a Mini-BeadBeater (BioSpec Products). Silica beads
and cell debris were removed by centrifugation. The proline concentration was determined by a published procedure (48), and the results were
expressed relative to those for the wild-type strain.
75
Se labeling experiment. C. difficile strains were cultivated in TY
medium with or without sodium selenite (50 nM, 4 Ci of 75Se, University of Missouri Research Reactor), and cell extracts were obtained as
previously described (38). The protein concentration was determined by
the Bradford assay (49) using bovine serum albumin as a standard. Selenoproteins in cell extracts were identified after electrophoresis in 15%
polyacrylamide gels containing SDS and visualization of radioisotope
bands by PhosphorImager analysis (Molecular Dynamics), after overlaying a Coomassie blue-stained gel to determine the approximate molecular
weights of the radioactive protein bands.

RESULTS

Stickland-type metabolism of proline is required for optimal
growth of C. difficile. In many Clostridium spp., including C.
difficile, Stickland reactions are thought to be important for
growth, at least under certain conditions (38, 50). In order to
confirm the role of Stickland reactions in growth of C. difficile, we
introduced insertion mutations into the prdB and grdA genes (Fig.
2). Insertional disruptions were verified by PCR (see Materials and
Methods), and a Southern blot confirmed that each mutant strain
had a single intron insertion (Fig. 3A). The resulting strains, LB-
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Primer name

Bouillaut et al.

FIG 4 Growth of C. difficile wild-type and mutant strains supplemented with L-proline or glycine. C. difficile wild-type (JIR8094 [Œ]), LB-CD4 (prdB::ermB [{]),
and LB-CD12 (grdA::ermB [o]) strains were grown in TY medium alone or supplemented with 30 mM L-proline (A) or 30 mM glycine (B). The C. difficile wild
type (JIR8094 []) was grown in TY medium alone. Cultures were grown anaerobically in a microtiter plate format at 37°C, and OD600 measurements were taken
every 10 min using a plate reader (Bio-Tek).
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FIG 3 Mutant characterization. (A) Southern blot analysis of HindIII-digested
genomic DNA from wild-type (JIR8094) (a), prdB mutant (LB-CD4) (b), and
grdA mutant (LB-CD12) (c) strains with an intron probe. (B) Radiolabeling (75Se)
of C. difficile wild-type and mutant strains. Wild-type (JIR8094), grdA mutant
(LB-CD12), and prdB mutant (LB-CD4) strains were grown in TY medium with
75
Se (4 Ci) for 24 h, harvested, and lysed by sonication. The extracts were subjected to SDS-15% polyacrylamide gel electrophoresis.

CD4 and LB-CD12, respectively, were tested for the ability to produce the selenoenzymes PR and GR by labeling of the proteins
with 75Se. Figure 3B shows that three major radioactive bands
corresponding to the PrdB subunit of PR and the GrdA and GrdB
subunits of GR were detected in extracts of wild-type cells. No
band corresponding to the PrdB subunit of PR was detected in
strain LB-CD4 (prdB mutant), and no bands corresponding to the
GrdA and GrdB subunits of GR were detected in the grdA null
mutant. The lack of the GrdB band in the grdA null mutant suggests that the grdA mutation is polar (grdB is downstream of grdA
[Fig. 2]). These results indicate that LB-CD4 and LB-CD12 are
defective in producing the cysteine-containing subunits of the selenoenzyme complexes PR and GR, respectively.
We then assessed the growth behavior of the mutant strains in
TY medium supplemented with 30 mM proline (Fig. 4A) or 30
mM glycine (Fig. 4B). The growth rate of the mutant strains was
similar to that of the wild-type (JIR8094) strain in TY medium
alone (Table 3) and in TY medium supplemented with glycine
(Fig. 4B and Table 3). In contrast, addition of L-proline to the
medium increased the growth rate of the wild-type and the grdA
mutant strains but had no effect on the doubling time or the
growth behavior of the prdB mutant (LB-CD4) (Fig. 4A and Table
3). It should be noted, however, that at low cell densities, the
growth rates of all strains in all media were similar, suggesting that
the bacteria do not begin to utilize proline until some other constituents of TY medium have been consumed. In addition, the
growth of the mutant strains in defined medium (14) supplemented with proline was appraised. Surprisingly, mutants were
viable and did not exhibit a severe growth defect compared to the

Regulation of C. difﬁcile Stickland Reactions

TABLE 3 Doubling times of wild-type and mutant strains in TY
medium with proline and glycinea
Doubling time (min) in:
Strain

Genotype

TY medium
alone

TY medium
⫹ proline

TY medium
⫹ glycine

JIR8094
LB-CD4
LB-CD12
LB-CD8

Wild type
prdB::erm
grdA::erm
prdR::erm

55.41 ⫾ 2.00
57.43 ⫾ 2.43
57.44 ⫾ 3.00
63.83 ⫾ 6.99

41.51 ⫾ 0.18
55.81 ⫾ 0.68
39.11 ⫾ 0.57
70.41 ⫾ 4.13

56.51 ⫾ 2.72
54.43 ⫾ 2.57
58.67 ⫾ 1.57
64.15 ⫾ 4.63

a
Strains were grown in TY medium alone or supplemented with 30 mM L-proline or 30
mM glycine. Doubling time was calculated during a 60-min period starting at 120 min
of growth; values are means ⫾ standard deviations.
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wild type (data not shown), suggesting that other metabolic pathways bypass the lack of a functional PR or GR. Therefore, the
proline reductase pathway is needed for optimal growth of C.
difficile in proline-supplemented medium, but the glycine reduction pathway does not play a significant role in the growth of C.
difficile under the conditions tested.
Proline activates transcription of the prd operon and inhibits
transcription of the grd operon. It has been shown previously for
C. difficile that addition of glycine to the growth medium increases
the level of GR and that addition of proline to the growth medium
both increases PR levels and decreases GR levels (38). To see if
these effects could be explained by regulation at the transcriptional level, we used qPCR to compare the relative amounts of
prdA, prdD, prdF, and grdE mRNAs in the mutant and wild-type
strains. As shown in Fig. 5A, the level of prdA mRNA increased
about 10-fold when wild-type cells were grown in the presence of
30 mM L-proline. Similarly, prdD and prdF transcripts were about
10-fold more abundant in the presence of exogenous L-proline
(Fig. 5C and D). The levels of grdE mRNA increased about 3-fold
in wild-type cells grown in the presence of 30 mM glycine (Fig.
5B). Interestingly, we found that grdE mRNA in the wild-type
strain was reduced about 80-fold when proline was added to the
medium (Fig. 5B), consistent with the reduced amount of GR
protein found in cells grown with proline (18). These data demonstrate that the prd and grd gene clusters are induced at the transcriptional level in response to proline and glycine, respectively,
and that proline plays a role in the transcription of the grd genes.
PrdR is required for proline-dependent activation of the prd
pathway. Jackson et al. (38) reported the presence, immediately
upstream of the C. difficile prd operon, of a 1,761-bp open reading
frame, named prdR, that encodes a putative activator of sigma-54dependent transcription. A previous study revealed that prdR homologs are found upstream of the proline reductase gene cluster
in most of the species that possess such genes (51). BLAST analysis
indicated that prdR is also present upstream of a prd gene cluster in
all sequenced C. difficile genomes (data not shown). To test
whether PrdR plays a role in the proline-dependent regulation of
the Stickland reaction genes, we created an insertion mutation in
prdR, using TargeTron technology (see Materials and Methods).
Disruption of the prdR gene was verified by PCR (see Materials
and Methods). Using qPCR, we measured the relative amounts of
prdA, prdD, prdF, and grdE mRNAs in the wild-type and prdR
mutant (LB-CD8) strains. Even in the absence of exogenous proline, the amount of prdA transcript in the prdR mutant was reduced about 2-fold compared to that in the wild type (Fig. 5A).
Moreover, when the cells were grown in the presence of proline,

prdA mRNA levels were ⬃35-fold lower in the prdR mutant than
in wild-type cells (Fig. 5A). Similarly, prdD and prdF transcripts
were less abundant in the prdR mutant than in the wild-type strain
grown in TY medium containing L-proline (Fig. 5C and D) or in
TY medium alone. Interestingly, grdE levels were increased about
3-fold in the prdR mutant compared to those in the wild type and
were not affected by the presence of proline in the medium (Fig.
5B), suggesting that PrdR participates in proline-dependent negative regulation of the grd operon.
Upstream of prdR, we found two genes, CD3246 and prdC. In
C. sticklandii, prdC encodes a selenoprotein required for electron
transfer by the PR complex (51). Despite the lack of a selenium
signature in C. difficile PrdC, we hypothesized that PrdC might be
part of the PR complex and thus might be regulated by PrdR. To
test this hypothesis, we measured by qPCR the amount of prdC
mRNA in the wild type and prdR mutant. We observed that prdC
levels increased about 10-fold when wild-type cells were grown in
the presence of L-proline (Fig. 5E). In the prdR mutant, prdC levels
were 2-fold lower than in the wild type grown in TY medium alone
and 30-fold less abundant than in the wild type grown in TY medium supplemented with L-proline (Fig. 5E), suggesting that PrdR
is responsible for the proline-dependent activation of prdC expression.
To confirm that proline-dependent regulation was due to the
disruption of prdR, we complemented strain LB-CD8 (prdR mutant) in trans with a plasmid carrying the prdR coding sequence
and 260 bp of upstream sequence. The resulting strain, LB-CD14,
was tested for its ability to restore prdA mRNA to wild-type levels.
The empty vector, pBL58, was introduced into the wild-type
strain to control for plasmid presence. The strain containing
pBL58 (LB-CD13) and the wild-type strain exhibited comparable
levels of prdA mRNA (data not shown). As shown in Fig. 5A, prdA
levels in LB-CD14 were similar to or slightly higher than those in
the wild-type strain grown under the same conditions, i.e., with or
without added L-proline. Hence, we conclude that prdR is required for proline-dependent activation of the prd operon.
Given the importance of PrdR in the expression of the Stickland reaction genes and the role of PR in growth (see above), we
assessed the effect of a prdR mutation on growth in TY medium
with and without supplementation with L-proline or glycine. Results shown in Fig. 3 and Table 3 indicate that the prdR mutant
exhibited a slightly lower growth rate than the wild type under all
conditions tested. This result shows that PrdR is needed for maximal growth of C. difficile.
Effects of disruption of prdB and grdA on expression of Stickland metabolism genes. Because the presence of the Stickland
acceptors proline and glycine affects expression of the Stickland
metabolism genes, we hypothesized that the PR and GR enzymes
control their own expression by modulating the intracellular
pools of proline. To test this hypothesis, we first measured the
intracellular concentration of free proline in strains LB-CD4, LBCD8, and LB-CD12. As expected, free proline in LB-CD4 (prdB)
was about 5-fold more abundant than in the wild-type control. No
changes were observed in strain LB-CD12 (grdA) compared to the
wild type, and intermediate levels were observed in strain LB-CD8
(prdR) (Fig. 6). These data show that intracellular proline concentrations depend on the activity of PR but not on the activity of GR.
Therefore, we tested if expression of Stickland metabolism
genes was altered in the absence of PR. The level of prdA mRNA in
strain LB-CD4 (prdB) was much higher than in wild-type cells

Bouillaut et al.

(Fig. 7A), consistent with the idea that blocking metabolism of
proline causes it to accumulate to a level that induces prdA transcription. Furthermore, whereas the addition of proline to wildtype cells led to a dramatic increase in prdA transcription, there
was no significant proline-dependent increase in prdA expression
in prdB mutant cells (Fig. 7A), implying that prdA transcription
had reached its maximum level in strain LB-CD4 without added
proline.
Surprisingly, grdE transcripts in strain LB-CD4 were more
abundant (⬃10-fold) than in wild-type cells (Fig. 7B) and ⬃3-fold
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more abundant than in the prdR mutant (Fig. 5B and 7B). Because
PrdR is present in LB-CD4 and the high intracellular concentration of proline in LB-CD4 does not repress grdE expression, we
conclude that PrdR does not directly mediate the inhibition of the
grd operon by proline. Instead, our results suggest that the activity
of PR plays a more direct role than does PrdR in negatively controlling expression of the glycine reductase pathway.
In a similar manner, we tested whether GR plays a role in regulating expression of the prd and grd genes. No changes in prdA
mRNA levels were seen in strain LB-CD12 (grdA) relative to those
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FIG 5 Expression of the prd and grd genes of wild-type and prdR mutant strains in the presence of L-proline or glycine. C. difficile wild-type (JIR8094), LB-CD8
(prdR::ermB), and LB-CD14 (prdR::ermB, prdR⫹) strains were grown to mid-exponential phase in TY medium alone or supplemented with 30 mM L-proline or
30 mM glycine. RNA was harvested, cDNA was synthesized, and qPCR was performed using gene-specific primers for prdA (A), grdE (B), prdF (C), prdD (D),
and prdC (E). Results were normalized to an internal control gene (rpoC) and are presented as the ratio of each transcript level to that of wild-type cells grown
in TY medium. The means and standard deviations of at least three biological replicates, each assayed in triplicate, are shown, with the exception of LB-CD8
samples in panels C, D, and E, for which data were obtained from a single biological replicate performed in triplicate.

Regulation of C. difﬁcile Stickland Reactions

wild-type (JIR8094), LB-CD4 (prdA::ermB), LB-CD12 (grdA::ermB), and LBCD8 (prdR::ermB) strains harvested after growth to mid-exponential phase in
TY medium were assayed for free proline using a published procedure (48),
and the results were expressed relative to those for the wild-type strain. Results
represent the means and standard deviations of three biological replicates.

in wild-type cells when the cells were grown in the presence of
proline (Fig. 7A). However, we noticed a small increase (⬃3-fold)
in the amount of prdA transcript in the grdA mutant grown with
or without glycine, indicating that GR plays a minor role in the
repression of PR. In contrast, grdE levels in LB-CD12 were ⬃10fold higher than in wild-type cells and ⬃12-fold more abundant in
glycine-supplemented medium (Fig. 7B). Furthermore, induction
of grdE expression in the presence of glycine was notably higher in
the grdA mutant than in the wild-type strain (Fig. 7B). These results indicate that the grd gene cluster is activated by glycine and

DISCUSSION

Stickland metabolism has been shown to be an important source
of energy for nontoxigenic Clostridium spp. in media containing
amino acids as sole carbon and nitrogen sources. For C. difficile,
both glycine and L-proline are required for optimal growth in
defined media (50, 52, 53). In addition, Jackson et al. (38) suggested that because of the selenium requirement of C. difficile for
growth in limiting basal medium, the Stickland selenium-containing reductases (PR and GR) play a key role in the physiology of
the bacteria. In the current work, we show that even in rich complex medium where bacteria can find and utilize a multitude of
carbon and nitrogen sources, the proline-dependent expression of
the PR is used for optimal growth of C. difficile (Fig. 4). However,

FIG 7 Expression of the prdA and grdE genes of wild-type and mutant strains in the presence of L-proline or glycine. C. difficile wild-type (JIR8094), LB-CD4
(prdB::ermB), and LB-CD12 (grdA::ermB) strains were grown to mid-exponential phase in TY medium alone or supplemented with 30 mM L-proline or 30 mM
glycine. RNA was harvested, cDNA was synthesized, and qPCR was performed using gene-specific primers for prdA (A) and grdE (B). Results were normalized
to an internal control gene (rpoC) and are presented as the ratio of each transcript level to that of wild-type cells grown in BHIS. The means and standard
deviations of at least three biological replicates, each assayed in triplicate, are shown.
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FIG 6 Analysis of proline content in C. difficile cells. Extracts from C. difficile

repressed directly or indirectly by GR or by another protein or
metabolite product of the grd gene cluster.
Effects of disruption of prdB and prdR on expression of a C.
difficile toxin gene. The presence of certain amino acids, including proline, inhibits toxin production (13, 14). To test whether the
effect of proline on toxin production is mediated by the Stickland
reactions, we measured the relative amounts of tcdA transcript in
wild-type, LB-CD4, and LB-CD8 strains in the early stationary
phase of growth. We observed that tcdA mRNA levels decreased
about 2.5-fold (P value ⬍ 0.05) when wild-type cells were grown
in the presence of exogenous proline (Fig. 8). Similarly, tcdA levels in
LB-CD4 grown with or without proline were ⬃2.5-fold lower than in
the wild-type cells (Fig. 8). On the other hand, we observed similar (or
slightly higher) levels of tcdA transcripts in strain LB-CD8 compared
to those in the wild type in cells grown without proline supplementation. However, the relative amount of tcdA mRNA in LB-CD8 was
⬃4-fold higher than in the wild type grown in the presence of exogenous proline, suggesting that PrdR represses tcdA expression. Thus,
this result indicates that proline negatively affects toxin expression at
the transcriptional level and shows that PrdR mediates this repression
either directly or indirectly.
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of L-proline. C. difficile wild-type (JIR8094), LB-CD4 (prdB::ermB), and LB-CD8
(prdR::ermB) strains were grown for 7 h to stationary phase in TY medium alone or
supplemented with 30 mM L-proline. RNA was harvested, cDNA was synthesized,
and qPCR was performed using gene-specific primers for tcdA. Results were normalized to an internal control gene (rpoC) and are presented as the ratio of each
transcript level to that of wild-type cells grown in TY medium. The means and
standard deviations of biological replicates are shown.

the lack of GR does not affect growth in rich medium. Hence, the
proline pathway of Stickland metabolism might be an important
source of energy in rich medium but the glycine pathway is not.
It has been shown previously for C. difficile that (i) proline
stimulates production of PR and inhibits production of GR (38)
and (ii) glycine stimulates production of GR. In addition, an earlier report (54) indicated that supplementation of the medium
with L-proline decreases GR activity in C. sporogenes and suggested
that the inhibition occurs at the level of GR synthesis. We show
here that addition of proline to the medium increases the expression of the prd genes and decreases the expression of grdE (Fig. 5A
and B). Furthermore, we identified PrdR, an apparent sigma-54dependent activator encoded by a gene located upstream of the
prd operon (Fig. 2), as the mediator of proline-dependent activation of the prd gene cluster and prdC and proline-dependent repression of the grd operon (Fig. 5). We also found that glycine
activates expression of grdE and that a functional PR is required
for proline-dependent repression of grdE. (The prdB mutation in
fact resulted in increased expression of grdE [Fig. 5B and Fig. 7].)
Given that the prdB mutant accumulates proline and that proline
seems to activate PrdR, we surmise that the proline-dependent
repression of grdE expression is not directly mediated by PrdR.
If it is not activation of PrdR that explains repression of grdE in
proline-containing medium, what could be responsible? First, the
enzymatic activity of PR could produce an inhibitor of grdE expression or consume an activator of grdE. Second, the prdB mutation is likely to have a polar effect on expression of downstream
genes, including prdF, which encodes proline racemase. If D-proline, the substrate of PR, rather than L-proline regulates grdE expression, the absence of prdF expression in a prdB mutant would
limit inhibition of grdE expression. Alternatively, 5-aminovaler-
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